Recipient-Related Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Primary graft dysfunction (PGD) is the main cause of early morbidity and mortality after lung transplantation. Previous studies have yielded conflicting results for PGD risk factors. Herein, we carried out a systematic review and meta-analysis of published literature to identify recipient-related clinical risk factors associated with PGD development. METHOD: A systematic search of electronic databases (PubMed, Embase, Web of Science, Cochrane CENTRAL, and Scopus) for studies published from 1970 to 2013 was performed. Cohort, case-control, or cross-sectional studies that examined recipient-related risk factors of PGD were included. The odds ratios (ORs) or mean differences (MDs) were calculated using random-effects models. RESULT: Thirteen studies involving 10042 recipients met final inclusion criteria. From the pooled analyses, female gender (OR 1.38, 95% CI 1.09 to 1.75), African American (OR 1.82, 95%CI 1.36 to 2.45), idiopathic pulmonary fibrosis (IPF) (OR 1.78, 95% CI 1.49 to 2.13), sarcoidosis (OR 4.25, 95% CI 1.09 to 16.52), primary pulmonary hypertension (PPH) (OR 3.73, 95%CI 2.16 to 6.46), elevated BMI (BMI≥25 kg/m2) (OR 1.83, 95% CI 1.26 to 2.64), and use of cardiopulmonary bypass (CPB) (OR 2.29, 95%CI 1.43 to 3.65) were significantly associated with increased risk of PGD. Age, cystic fibrosis, secondary pulmonary hypertension (SPH), intra-operative inhaled nitric oxide (NO), or lung transplant type (single or bilateral) were not significantly associated with PGD development (all P>0.05). Moreover, a nearly 4 fold increased risk of short-term mortality was observed in patients with PGD (OR 3.95, 95% CI 2.80 to 5.57). CONCLUSIONS: Our analysis identified several recipient related risk factors for development of PGD. The identification of higher-risk recipients and further research into the underlying mechanisms may lead to selective therapies aimed at reducing this reperfusion injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Clinical risk factors for primary graft dysfunction after lung transplantation
Diamond, J. M., Lee, J. C., Kawut, S. M., Shah, R. J., Localio, A. R., Bellamy, S. L., Lederer, D. J., Cantu, E., Kohl, B. A., Lama, V. N., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201210-1865oc · Cited by 687 · cited 7×
“45 yr) or younger (,21 yr) donor age, and closed head injury as a cause of death [9,10,18,19,20].”
BackgroundMethodResultInfluentialMadill, J., Gutierrez, C., Grossman, J., Allard, J., Chan, C., Hutcheon, M., & Keshavjee, S. H. (2001) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(00)00315-6 · Cited by 157
Risk factors for early primary graft dysfunction after lung transplantation: a registry study
Kuntz, C. L., Hadjiliadis, D., Ahya, V. N., Kotloff, R. M., Pochettino, A., Lewis, J., & Christie, J. D. (2009) · Clinical Transplantation · doi:10.1111/j.1399-0012.2008.00951.x · Cited by 138 · cited 17×
“Nonetheless, the need for blood products administration has been shown to collinear with other PGD risk factors, including PPH and the use of CPB, and unmeasured operative characteristics may also lead to transfusion requirements [54].”
BackgroundResultInfluential
Cited by
Van Raemdonck, D., Hartwig, M. G., Hertz, M. I., Davis, R. D., Cypel, M., Hayes, D., Ivulich, S., Kukreja, J., Lease, E. D., Loor, G., et al. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.07.013 · Cited by 128
Upala, S., Panichsillapakit, T., Wijarnpreecha, K., Jaruvongvanich, V., & Sanguankeo, A. (2016) · Transplant International · doi:10.1111/tri.12721 · Cited by 81
“Our findings are consistent with those of a previously published meta-analysis of recipient-related clinical risk factors for PGD after lung transplantation [32].”
ResultExtracorporeal life support during lung transplantation
Coster, J. N., & Loor, G. (2021) · Indian Journal of Thoracic and Cardiovascular Surgery · doi:10.1007/s12055-021-01175-4 · Cited by 14
“CPB has also been associated with increased systemic inflammation [10] and postoperative allograft dysfunction [1, 10, 12, 16, 17].”
BackgroundResultJawitz, O. K., Raman, V., Bryner, B. S., Klapper, J., & Hartwig, M. G. (2021) · Transplant International · doi:10.1111/tri.13784 · Cited by 12
Metadata
- Authors
- Liu, Y., Liu, Y., Su, L., & Jiang, S.-J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-03-21
- Volume
- 9
- Issue
- 3
- Pages
- e92773
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1991401324
- Cited by
- 157
- References
- 4
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.